Soundarya Palanisamy
Senior Industry Advisor

Soundarya is an Industry Advisor with a focus on data science, based in Germany and is part of the Health and Life Sciences Practice at SAS. She supports clients by providing guidance on their journey of digital transformation through the usage of AI, Analytics and Technology. She is specialized in machine learning, text mining and analytical life cycle management. In her previous role at Regenold, she headed the data science team, which helped in translating the client’s business needs to value-generating solutions using open source and SAS Viya. She holds a Bachelor of Engineering in Computer Science from Anna University, India and a Master of Science in Informatics with specialization in Cognitive Technical Systems from the University of Freiburg, Germany. There, she worked on a project for BMW on the challenges faced by autonomous cars in traffic situations and lane changes. And later at Fraunhofer Institute for solar energy systems towards automatic labelling of sensor data from smart buildings using machine learning methods.

Advanced Analytics | Analytics
Soundarya Palanisamy 0
Decentralizing clinical trials: how COVID-19 has changed drug development

The COVID-19 pandemic brought an enormous urgency to the life sciences sector. Companies vied for suitable treatments and in less than a year, COVID-19 vaccines were developed. This demonstrated clearly that the sector could move at speed when necessary. Though vaccines were supported by regulators, inefficiencies in vaccine and drug development were exposed.